Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000706373 | SCV000835417 | pathogenic | Congenital myasthenic syndrome 4A | 2023-08-30 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 8 of the CHRNE gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CHRNE are known to be pathogenic (PMID: 22678886). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with congenital myasthenic syndrome (PMID: 14592868). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as IVS8-1G>A. ClinVar contains an entry for this variant (Variation ID: 582326). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000706373 | SCV004212570 | pathogenic | Congenital myasthenic syndrome 4A | 2023-10-17 | criteria provided, single submitter | clinical testing |